Stockscreener 앱 받기
7.6233
0.65%
-0.0567
전일 마감가:
$7.68
열려 있는:
$7.67
하루 거래량:
112.53K
Relative Volume:
0.45
시가총액:
$176.86M
수익:
$155.00K
순이익/손실:
$-30.01M
주가수익비율:
-4.5649
EPS:
-1.67
순현금흐름:
$-11.98M
1주 성능:
+2.69%
1개월 성능:
+4.81%
6개월 성능:
+60.29%
1년 성능:
-27.75%
1일 변동 폭
$7.51
$7.92
1주일 범위
$7.19
$8.0602
52주 변동 폭
$4.32
$11.03
Inmune Bio Inc Stock (INMB) Company Profile
명칭
Inmune Bio Inc
전화
(858) 964-3720
주소
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
7.62 | 187.08M | 155.00K | -30.01M | -11.98M | -1.67 |
|
ONC
Beigene Ltd Adr
|
236.69 | 24.29B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.33 | 110.94B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.251 | 45.05M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.75 | 61.99B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.62 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-21 | 개시 | Alliance Global Partners | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Scotiabank | Sector Outperform |
| 2023-06-01 | 개시 | Robert W. Baird | Outperform |
| 2022-05-24 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-21 | 개시 | B. Riley Securities | Buy |
| 2021-01-22 | 재확인 | Maxim Group | Buy |
| 2020-09-01 | 개시 | BTIG Research | Buy |
| 2020-07-15 | 재확인 | H.C. Wainwright | Buy |
모두보기
Inmune Bio Inc 주식(INMB)의 최신 뉴스
Where are the Opportunities in (INMB) - news.stocktradersdaily.com
Dimensional Fund Advisors LP Acquires 10,491 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World
INmune Bio: XPro Trial Readout In Alzheimer’s Disease Offers Big Opportunity (NASDAQ:INMB) - Seeking Alpha
Wells Fargo & Company MN Buys 2,155 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World
INmune Bio to Attend RBC Healthcare Conference - TipRanks
INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times
INmune Bio Sets Stage for Key Biotech Insights at RBC Healthcare Conference Next Week - Stock Titan
Raymond James raises INmune Bio stock target to $23 - MSN
Barclays PLC Increases Stake in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN
INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey
INmune Bio’s Earnings Call: Promise and Challenges - TipRanks
Mariner LLC Acquires New Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
Earnings call transcript: INmune Bio Q1 2025 shows narrowed losses, stock rises - Investing.com
INmune Bio Reports Q1 2025 Results and Updates - TipRanks
INMUNE BIO Earnings Results: $INMB Reports Quarterly Earnings - Nasdaq
INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - The Manila Times
(INMB) Trading Signals - news.stocktradersdaily.com
INmune Bio appoints new accounting firm By Investing.com - Investing.com Nigeria
INmune Bio appoints new accounting firm - Investing.com
INmune Bio Inc (INMB) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
JPMorgan Chase & Co. Has $53,000 Stock Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
INmune Bio Inc expected to post a loss of 47 cents a shareEarnings Preview - TradingView
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - The Manila Times
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on ... - Eagle-Tribune
Renaissance Technologies LLC Increases Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
LPL Financial LLC Boosts Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
INmune Bio, Inc. (NASDAQ:INMB) Receives $22.80 Average PT from Analysts - Defense World
INmune Bio (INMB) Expected to Announce Quarterly Earnings on Thursday - Defense World
Geode Capital Management LLC Has $1.70 Million Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
A stock that deserves closer examination: INmune Bio Inc (INMB) - uspostnews.com
(INMB) Technical Data - news.stocktradersdaily.com
Inmune Bio Secures Favorable Patentability Opinion for CORDStrom™ - TipRanks
INmune Bio secures key patent opinion for CORDStrom platform By Investing.com - Investing.com South Africa
INmune Bio Receives Favorable Opinion from USPTO on CORDStrom Patent Application - marketscreener.com
INmune Bio Inc. Achieves Key Patent Milestone for CORDStrom™ Cell Therapy Platform - Nasdaq
INmune Bio secures key patent opinion for CORDStrom platform - Investing.com
Patent Win: INmune Bio's Revolutionary Cell Therapy Secures 20+ Years Protection - Stock Titan
INmune Bio (INMB) Partners with CGT Catapult for Large-Scale Cel - GuruFocus
INmune Bio Partners with Cell and Gene Therapy Catapult - MSN
INmune Bio (INMB) Partners to Enhance Cell Therapy Production - GuruFocus
INmune Bio in pact with Cell and Gene Therapy Catapult (INMB) - Seeking Alpha
INmune Bio, CGT Catapult Partner To Scale CORDStrom Manufacturing For Commercial Launch - Nasdaq
INmune Bio Collaborating With Cell and Gene Therapy Catapult to Scale Manufacturing - MarketScreener
INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness - The Manila Times
INmune Bio's Game-Changing Partnership Accelerates CORDStrom Production for 4,000 RDEB Patients - Stock Titan
Inmune Bio Presents Alzheimer’s Trial Data at Conference - TipRanks
INmune Bio, Inc. (NASDAQ:INMB) Receives $22.80 Average Price Target from Brokerages - Defense World
Trend Tracker for (INMB) - news.stocktradersdaily.com
INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update - ADVFN
INmune Bio Presents MINDFuL Trial Data At AD/PD 2025 - Nasdaq
Inmune Bio Inc (INMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
2.08%
자본화:
|
볼륨(24시간):